Keywords: Hikma, Promopharm, Added equity stake, Argatroban, Thrombocytopenia, Anticoagulant

Hikma adds to stake in Promopharm; gets US appro for argatroban

Article | 22 January 2012

Fast-growing Jordan headquartered Hikma Pharmaceuticals (LSE: HIK) says that it has increased its stake in Morocco-based Promopharm (Societe de Promotion ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Hikma Pharmaceuticals

Promopharm

Go to company listing

Related Drugs

Argatroban

Go to drug listing